Search

everythinglearnresearchcommunity

for

Search:↓

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Some ovarian tumors can cause masculinization, and it's important to check for various causes when this symptom is present.

A new method was created to analyze certain chemicals in the urine of alopecia areata patients, revealing they have higher metanephrine content. This method can also be used for other related diseases.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Lifestyle changes like diet and exercise are key for treating overweight women with polycystic ovary syndrome.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

Platelet-rich plasma injections are a cheap and effective way to reduce hair loss and improve hair quality in people with mild to moderate androgenetic alopecia.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Finasteride can slow hair loss and promote growth in postmenopausal women.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

No definitive link between finasteride and male breast cancer, but further research is needed.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.